Current use and future potential of organometallic radiopharmaceuticals

European Journal of Nuclear Medicine

Volumn 29, Issue 11, 2002, Pages 1529-1542

  Schibli, Roger ^a,b   Schubiger, August P ^a,b  

^a PAUL SCHERRER INSTITUTE   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Biomolecule; Bioorganometallic; Organometallic; Radiopharmaceuticals; Tricarbonyl

Indexed keywords

[2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; IODOHIPPURATE SODIUM I 125; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NEUROTENSIN[8-13]; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; RHENIUM COMPLEX; RUPURRAN RU 97; TECHNETIUM DERIVATIVE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; IMMUNOGLOBULIN FRAGMENT; PROTEIN; RHENIUM;

BINDING AFFINITY; CHELATION; CRYSTAL STRUCTURE; DRUG CLEARANCE; DRUG DISTRIBUTION; HYDROLYSIS; HYDROPHILICITY; IC 50; ISOTOPE LABELING; METHODOLOGY; NONHUMAN; OXIDATION; PROTON TRANSPORT; REVIEW; TECHNOLOGY; CHEMICAL STRUCTURE; CHEMISTRY; INSTRUMENTATION; RADIOCHEMISTRY; SCINTISCANNING;

IMMUNOGLOBULIN FRAGMENTS; ISOTOPE LABELING; MODELS, MOLECULAR; ORGANOMETALLIC COMPOUNDS; PROTEINS; RADIOCHEMISTRY; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RHENIUM; TECHNETIUM COMPOUNDS;

EID: 0036033839     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0900-8     Document Type: Review

References (68)

1. Holman BL, Jones AG, Listerjames J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ. A New Tc-99m-labelled myocardial imaging agent, hexakis(tert-butylisoni-trile)-technetium(I) Tc-99m Tbi - Initial experience in the human. J Nucl Med 1984; 25:1350-1355.
2. Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. Characterization of multidrug-resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 1995; 34:12210-12220.
3. Herman LW, Sharma V, Kronauge JF, Barbarics E, Herman LA, Piwnica-Worms D. Novel hexakis(areneisonitrile)technetium(I) complexes as radioligands targeted to the multidrug-resistance P-glycoprotein. J Med Chem 1995; 38:2955-2963.
4. 3]. J Organomet Chem 1995; 493:119-127.
5. - in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc 1998; 120:7987-7988.
6. +. J Am Chem Soc 2001; 123:3135-3136.
7. + and synthesis of tailor-made bifunctional ligand systems. Bioconjugate Chem 2002; in press.
8. Top S, Vessieres A, Jaouen G. Synthetic strategy for organometallic complexes of rhenium with exceptionally high-affinity for the estradiol-receptor - Their potential use as imaging and therapeutic agents. J Chem Soc-Chem Commun 1994: 453-454.
9. Wenzel M. Tc-99m Labeling of cymantrene-analogs with different substituents - A new approach to Tc-99m radiodagnostics. J Label Compd Radiopharm 1992; 31:641-650.
10. Minutolo F, Katzenellenbogen JA. A convenient three-component synthesis of substituted cyclopentadienyl tricarbonyl rhenium complexes. J Am Chem Soc 1998; 120:4514-4515.
11. Minutolo F, Katzenellenbogen JA. Boronic acids in the three-component synthesis of carbon-substituted cyclopentadienyl tricarbonyl rhenium complexes. J Am Chem Soc 1998; 120: 13264-13265.
12. Winter M. Organorhenium compounds. Gmelin handbook of inorganic chemistry, vol. 1, 8th edn. Berlin, Heidelberg, New York: Springer, 1989.
13. Egli A, Alberto R, Tannahill L, Schibli R, Abram U, Schaffland A, Waibel R, Tourwe D, Jeannin L, Iterbeke K, Schubiger PA. Organometallic Tc-99m-aquaion labels peptide to an unprecedented high specific activity. J Nucl Med 1999; 40:1913-1917.
14. Schibli R, La Bella R, Alberto R, Garcia-Garayoa E, Ortner K, Abram U, Schubiger PA. Influence of the denticity of ligand systems on the in vitro and in vivo behavior of Tc-99m(I)-tricarbonyl complexes: A hint for the future functionalization of biomolecules. Bioconjugate Chem 2000; 11:345-351.
15. + core. Nucl Med Biol 1999; 26:711-716.
16. 3 moieties to biologically active molecules. Bio-conjugate Chem 2000; 11:414-424.
17. 188Re-tricarbonyl preparation for high specific activity labeling of biomolecules. J Label Compd Radiopharm 2001; 44 Suppl 1:S723-S725.
18. 99mTc-tricarbonyl. J Label Compd Radiopharm 2001; 44 Suppl 1:S57-S59.
19. Petrig J, Schibli R, Dumas C, Alberto R, Schubiger PA. Derivatization of glucose and 2-deoxyglucose for transition metal complexation: Substitution reactions with organometallic Tc-99m and Re precursors and fundamental NMR investigations. Chemistry - A European Journal 2001; 7:1868-1873.
20. Jaouen G, Top S, Vessieres A, Pigeon P, Leclercq G, Laios I. First anti-oestrogen in the cyclopentadienyl rhenium tricarbonyl series. Synthesis and study of antiproliferative effects. Chem Commun 2001:383-384.
21. Spradau TW, Katzenellenbogen JA. Ligands for the estrogen receptor, containing cyclopentadienyltricarbonylrhenium units. Bioorg Med Chem Lett 1998; 8:3235-3240.
22. Wenzel M, Klinge C. Tc-99m-labeled estradiol derivatives - Synthesis, organ distribution and tumor affinity. J Label Compd Radiopharm 1994; 34:981-987.
23. Top S, Elhafa H, Vessieres A, Quivy J, Vaissermann J, Hughes DW, McGlinchey MJ, Mornon JP, Thoreau E, Jaouen G. Rhenium carbonyl-complexes of beta-estradiol derivatives with high-affinity for the estradiol-receptor - An approach to selective organometallic radiopharmaceuticals. J Am Chem Soc 1995; 117:8372-8380.
24. 3 substituted steroids. Tetrahedron 2001; 57:3939-3944.
25. Tang J, Top S, Vessieres A, Sellier N, Vaissermann J, Jaouen G. Synthesis of 17α-ruthenocenyl-17 beta-oestradiol and its potential as a radiopharmaceutical agent. Appl Organomet Chem 1997; 11:771-781.
26. Wust F, Carlson KE, Katzenellenbogen JA, Spies H, Johannsen B. Synthesis and binding affinities of new 17 α-substituted estradiol-rhenium "n+1" mixed-ligand and thioethercarbonyl complexes. Steroids 1998; 63:665-671.
27. Wust F, Skaddan MB, Leibnitz P, Spies H, Katzenellenbogen JA, Johannsen B. Synthesis of novel progestin-rhenium conjugates as potential ligands for the progesterone receptor. Bioorg Med Chem 1999; 7:1827-1835.
28. Wenzel M, Klinge C, Saidi M. Tc-99m and deuterium-labeled radiodiagnostics - Comparison of HMPAO with cytectrene derivatives of cyclic amines. J Label Compd Radiopharm 1993; 33:1039-1051.
29. Kuntschke D, Wenzel M, Schulze P. New Tc-99m-cytectrene amine compounds as specific brain imaging agents. J Label Compd Radiopharm 1995; 36:193-203.
30. Wenzel M, Saidi M. Esters of Tc-99m labeled cytectrenecarboxyxlic acid with alcohols of cyclic amines as cerebral radiodiagnostic agents. J Label Compd Radiopharm 1993; 33:77-80.
31. Cesati RR, Tamagnan G, Baldwin RM, Zoghbi SS, Innis RB, Kula NS, Baldessarini RJ, Katzenellenbogen JA. Synthesis of cyclopentadienyltricarbonyl rhenium phenyltropanes by double ligand transfer: Organometallic ligands for the dopamine transporter. Bioconjugate Chem 2002; 13:29-39.
32. Hoepping A, Reisgys M, Brust P, Seifert S, Spies H, Alberto R, Johannsen B. TROTEC-1: A new high-affinity ligand for labeling of the dopamine transporter. J Med Chem 1998; 41:4429-4432.
33. Tamagnan G, Baldwin RM, Kula NS, Baldessarini RJ, Innis RB. Cyclopentadienyltricarbonylrheniumbenzazepines: Synthesis and binding affinity. Bioorg Med Chem Lett 2000; 10:1113-1115.
34. Dyszlewski M, Blake H, Dahlheimer J, Piwnica-Worms D. Characterization of Tc-99m-tricarbonyl complexes as transporter substrates of the multidrug resistance (MDR1) P-glycoprotein. J Label Compd Radiopharm 2001; 44 Suppl 1:S63-S65.
35. Maresca KP, Kronauge JF, Babich JW, Carmel A, Marshall M, Jones A. Tc-99m-isonitriles for renal imaging. J Label Compd Radiopharm 2001; 44 Suppl 1:S72-S74.
36. 99mTc]metomidate as the tricarbonyl-conjugate. J Label Compd Radiopharm 2001; 44 Suppl. 1:S624-S626.
37. Du J, Hiltunen J, Marquez M, Nilsson S, Holmberg AR. Technetium-99m labelling of glycosylated somatostatin-14. Appl Radiat Isot 2001; 55:181-187.
38. 3His,Tyr]octreotate. J Label Compd Radiopharm 1999; 42 Suppl 1:S231-S233.
39. Brühlmeier M, Garcia-Garayoa E, Blanc A, Holzer B, Gergely S, Tourwé D, Schubiger AP, Bläuenstein P. Stabilization of neurotensin analogues: Effect on peptide catabolism, biodistribution and tumor binding. Nucl Med Biol 2002; 29:321-327.
40. Garcia-Garayoa E, Allemann-Tannahill L, Bläuenstein P, Willmann M, Carrel-Rémy N, Tourwé D, Iterbeke K, Conrath P, Schubiger AP. In vitro and in vivo evaluation of new radiolabeled neurotensin(8-13) analogues with high affinity for NT1 receptors. Nucl Med Biol 2001; 28:75-84.
41. Garcia-Garayoa E, Bläuenstein P, Brühlmeier M, Blanc A, Iterbeke K, Conrath P, Tourwé D, Schubiger AP. Preclinical evaluation of a new, stabilized neurotensin(8-13) pseudopeptide radiolabeled with Tc-99m. J Nucl Med 2002; 43:374-383.
42. 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. Bioconjugate Chem 2001; 12:1028-1034.
43. 99mTc(I) post-labeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjugate Chem 2002; 13:599-604.
44. Baidoo KE, Knight LC, Romano JE, Gabriel JL, Maurer AH. Synthesis and evaluation of new bifunctional chelator designed for labeling biomolecules by the technetium tricarbonyl technology. J Label Compd Radiopharm 2001; 44 Suppl 1:S66-S68.
45. Waibel R, Alberto R, Willuda J, Finnern R, Schibli R, Stichelberger A, Egli A, Abram U, Mach JP, Plückthun A, Schubiger PA. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 1999; 17:897-901.
46. Willuda J, Honegger A, Waibel R, Schubiger AP, Stahel R, Zangemeister-Wittke U, Plückthun A. High thermal stability is essential for tumor targeting of antibody fragments: Engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res 1999; 59:5758-5767.
47. + retains biological activity in vitro. Nucl Med Biol 2001; 28:243-250.
48. 188Re-C595 antibodies for radioimmunotherapy of bladder cancer. J Label Compd Radiopharm 2001; 44: S573-S575.
49. Pietzsch HJ, Johannsen B. Development of technetium-99m-based CNS receptor ligands: Have there been any advances? Eur J Nucl Med 2002; 29:263-275.
50. Kung MP, Stevenson DA, Plossl K, Meegalla SK, Beckwith A, Essman WD, Mu M, Lucki I, Kung HF. Tc-99m TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent. Eur J Nucl Med 1997; 24:372-380.
51. Kung HF, Kim HJ, Kung MP, Meegalla SK, Plossl K, Lee HK. Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur J Nucl Med 1996; 23:1527-1530.
52. Meegalla S, Plössel K, Kung M-P, Stevenson DA, Liable-Sands L, Rheingold AL, Kung HF. First example of a 99m-Tc complex as a dopamine transporter imaging agent. J Am Chem Soc 1995; 117:11037-11038.
53. + in bioorganometallic chemistry: Design, structure, and in vitro affinity of a 5-HT1A receptor ligand labeled with Tc-99m. J Am Chem Soc 1999; 121:6076-6077.
54. Wald J, Alberto R, Ortner K, Candreia L. Aqueous one-pot synthesis of derivatized cyclopentadienyl-tricarbonyl complexes of Tc-99m with an in situ CO source: Application to a serotonergic receptor ligand. Angew Chem-Int Edit 2001; 40:3062-3066.
55. Salmain M, Vessieres A, Brossier P, Butler IS, Jaouen G. Carbonylmetalloimmunoassay (Cmia) a new type of nonradioisotopic immunoassay - Principles and application to phenobarbital assay. J Immunol Methods 1992; 148:65-75.
56. Jaouen G, Vessieres A, Butler IS. Bioorganometallic chemistry - A future direction for transition-metal organometallic chemistry. Accounts Chem Res 1993; 26:361-369.
57. Jaouen G, Vessieres A. Transition-metal carbonyl estrogen-receptor assay. Pure Appl Chem 1985; 57:1865-1874.
58. Jaouen G, Vessieres A, Top S, Ismail AA, Butler IS. Metal-carbonyl fragments as a new class of markers in molecular biology. J Am Chem Soc 1985; 107:4778-4780.
59. Skaddan MB, Wust FR, Katzenellenbogen JA. Synthesis and binding affinities of novel re-containing 7 alpha-substituted estradiol complexes: Models for breast cancer imaging agents. J Org Chem 1999; 64:8108-8121.
60. 3-octreotide for imaging so-matostatin-receptor-positive tumors: Preclinical evaluation and comparison with In-111-octreotide. J Nucl Med 2000; 41:1114-1119.
61. Decristoforo C, Mather SJ, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R. Tc-99m-EDDA/HYNIC-TOC: A new Tc-99-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: First clinical results and intra-patient comparison with In-111-labelled octreotide derivatives. Eur J Nucl Med 2000; 27:1318-1325.
62. Vallabhajosula S, Moyer BR, ListerJames J, McBride BJ, Lipszyc H, Lee H, Bastidas D, Dean RT. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides. J Nucl Med 1996; 37:1016-1022.
63. Vincent JP. Neurotensin receptors: Binding properties, trans-duction pathways, and structure. Cell Mol Neurobiol 1995; 15:501-512.
64. Waibel R, Novak-Hofer I, Schibli R, Blauenstein P, Garcia-Garayoa E, Schwarzbach R, Zimmermann K, Pellikka R, Gasser O, Blanc A, Bruhlmeier M, Schubiger PA. Radiopharmaceuticals for targeted tumor diagnosis and therapy. Chimia 2000; 54:683-688.
65. Willuda J, Kubetzko S, Waibel R, Schubiger PA, Zangemeister-Wittke U, Plückthun A. Tumor targeting of mono-, di-, and tetravalent anti-p185(HER-2) miniantibodies multimerized by self-associating peptides. J Biol Chem 2001; 276:14385-14392.
66. 99mTc-tricarbonyl labeled single-chain antibody fragments for improved in vivo behavior in tumor targeting. J Label Compd Radiopharm 2001; 44 Suppl 1:S561-S563.
67. Coggin DK, Mathias CJ, Green MA. Investigation of Ga-67 dimethylgallium(III) acetylacetonate as a potential radiopharmaceutical. Nucl Med Biol 1994; 21:283-285.
68. Wenzel M, Meinhold H, Schachschneider G. Ru-labeled ruthenocenoyl-glycine: Comparison of the clearance with hippuran. Eur J Nucl Med 1985; 10:138-142.